Logo Université Laval
Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist
About Us
Our Congress
Recent Contributions
Editorials
My Waistline
Defining CMR
Definition and History
The Obesity and Type 2 Diabetes Epidemics
Epidemiology
Traditional Modifiable CVD Risk Factors
Type 2 Diabetes
Abdominal Obesity vs. CVD: Beyond Body Weight
Abdominal Obesity vs. Type 2 Diabetes: Beyond Body Weight
Visceral Adipose Tissue: the Culprit?
Complications of Visceral Obesity
Causes and Correlates of Visceral Obesity
A Marker of Ectopic Fat Deposition?
Evaluating CMR
Clinical Tools
Imaging Techniques
Assessing CVD Risk: Traditional Approaches
Metabolic Syndrome and Type 2 Diabetes/CVD Risk
Assessing Cardiometabolic Risk
Managing CMR
Targeting Traditional CVD Risk Factors in Patients With Abdominal Obesity
Residual Cardiometabolic Risk of Treated Patients
Effects of Weight Loss on Adipose Tissue Distribution
Managing Cardiometabolic Risk in Abdominally Obese Patients
Preventing Type 2 Diabetes
Documentation Centre
Donate
Documentation centre
Documentation centre
Keywords
Dates
From
To
Categories
Abdominal Obesity/Body Fat Distribution
Acute Coronary Syndromes
Adipokines
Adipose Tissue
Age
Brain Health
Cancer
Cardiometabolic Risk
Cardiovascular Disease
Childhood Obesity
Clinical Cardiology
Clinical Trials
Diabetes
Ectopic Fat
Epidemiology
Ethnicity
Genetics
Hypertension
Inflammation
Insulin Resistance
Interventional Cardiology
Lipids/Lipoproteins
Menopause
Metabolic Syndrome
Metabolism
Metabolism: Animal Studies
Metabolism: Human Studies
Nutrition
Obesity
Physical Activity/Exercise
Prevention
Respiratory Diseases
Sex Differences
Smoking
Steroid Hormones
Thrombosis
Weight Loss
Format
1
Slide Library
Expert Opinions
Webcasts
Key Publications
Image Base
Search
85-96 of 116 results
Sort by
More recent
Less recent
Alphabetical order (Title)
Alphabetical order (Author)
Apply
Page 8 of 10
Image Base
September 1, 2007
The endocannabinoid system and CB1 mechanism of action
The International Chair on Cardiometabolic Risk
Diabetes
Metabolism
Image Base
September 1, 2007
Risk of coronary heart disease (CHD) in U.S. adults according to subgroups of metabolic syndrome (MS) components
The International Chair on Cardiometabolic Risk
Metabolic Syndrome
Image Base
September 1, 2007
Number of metabolic syndrome abnormalities by NCEP-ATP III clinical criteria, diabetes, and prevalent CVD and hazard ratios of 10-year risk of fatal and non-fatal CVD
The International Chair on Cardiometabolic Risk
Diabetes
Metabolic Syndrome
Image Base
September 1, 2007
Effect of Orlistat on body weight in a four-year randomized, placebo-controlled clinical trial
The International Chair on Cardiometabolic Risk
Image Base
September 1, 2007
Effect of rimonabant on body weight over two years
The International Chair on Cardiometabolic Risk
Weight Loss
Image Base
September 1, 2007
The endocannabinoid system and cardiometabolic risk
The International Chair on Cardiometabolic Risk
Diabetes
Metabolism
Image Base
August 31, 2007
Basic illustration of the portal theory
The International Chair on Cardiometabolic Risk
Abdominal Obesity/Body Fat Distribution
Metabolic Syndrome
Metabolism
Image Base
August 31, 2007
Independent associations between liver fat, intra-abdominal fat, and cardiometabolic risk
The International Chair on Cardiometabolic Risk
Abdominal Obesity/Body Fat Distribution
Cardiometabolic Risk
Ectopic Fat
Image Base
August 31, 2007
Evidence for a greater relative accumulation of intra-abdominal fat in Japanese than Caucasian Americans
The International Chair on Cardiometabolic Risk
Abdominal Obesity/Body Fat Distribution
Ethnicity
Image Base
August 31, 2007
a) Sample meal plan of a healthy 1,200 kcal menu b) Sample meal plan of a healthy 1,600 kcal menu
The International Chair on Cardiometabolic Risk
Nutrition
Image Base
August 31, 2007
Key features of a "sensible" diet for achieving cardiometabolic health
The International Chair on Cardiometabolic Risk
Nutrition
Image Base
August 31, 2007
Classification of blood pressure for adults
The International Chair on Cardiometabolic Risk
Hypertension
Previous
1
...
7
8
9
10
Next
Go to page
of 10
GO